Results 1 to 10 of about 62,922 (204)
Pseudobulbar Affect in Parkinsonian Disorders: A Review [PDF]
Journal of Movement Disorders, 2019 Pseudobulbar affect (PBA) is a neurological symptom of inappropriate and uncontrollable laughter or crying that occurs secondary to a variety of neurological conditions, including parkinsonian disorders.
Mathew Hakimi, Carine W. Maurer
doaj +5 more sources
Neuropsychiatric disturbances in atypical parkinsonian disorders [PDF]
Neuropsychiatric Disease and Treatment, 2018 Daniele Belvisi,1 Isabella Berardelli,2 Antonio Suppa,1,3 Andrea Fabbrini,3 Massimo Pasquini,3 Maurizio Pompili,2 Giovanni Fabbrini1,3 1IRCCS Neuromed, Pozzilli, Italy; 2Department of Neurosciences, Mental Health and Sensory Organs, Suicide Prevention ...
Belvisi D +6 more
doaj +10 more sources
Assessing bradykinesia in Parkinsonian disorders [PDF]
Frontiers in Neurology, 2013 Objective: Bradykinesia is one of the clinical hallmarks of Parkinson’s disease (PD) and atypical Parkinsonian syndromes. Clinical ratings scales and technology based assessments have been developed to measure bradykinesia.
Gian ePal, Christopher G Goetz
doaj +4 more sources
Autonomic Dysfunctions in Parkinsonian Disorders [PDF]
Journal of Movement Disorders, 2009 Background and Purpose: Symptoms of autonomic dysfunctions are common in the patients with parkinsonian disorders. Because clinical features of autonomic dysfunctions are diverse, the comprehensive evaluation is essential for the appropriate management ...
Hyo-Jin Bae +2 more
doaj +5 more sources
Assisted Suicide in Parkinsonian Disorders [PDF]
Frontiers in Neurology, 2021 Background: Due to the high prevalence of suicidal ideation in Parkinson's Disease (PD) and exploratory data indicating a similar prevalence in atypical Parkinsonian disorders (APD), we sought to determine the frequency of assisted suicide (AS) as well ...
Georg S. Nuebling +5 more
doaj +7 more sources
Molecular Imaging in Parkinsonian Disorders—What’s New and Hot? [PDF]
Brain Sciences, 2022 Neurodegenerative parkinsonian disorders are characterized by a great diversity of clinical symptoms and underlying neuropathology, yet differential diagnosis during lifetime remains probabilistic.
Stéphane Prange +3 more
doaj +4 more sources
Therapeutic Application of rTMS in Atypical Parkinsonian Disorders. [PDF]
Behav Neurol, 2021 The terms atypical parkinsonian disorders (APDs) and Parkinson plus syndromes are mainly used to describe the four major entities of sporadic neuronal multisystem degeneration: progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and dementia with Lewy bodies (LBD). APDs are characterized by a variety of
Petsani C +7 more
europepmc +6 more sources
The neurogenetics of atypical parkinsonian disorders. [PDF]
Semin Neurol, 2014 Although classic Parkinson disease is the disorder most commonly associated with the clinical feature of parkinsonism, there is in fact a broader spectrum of disease represented by a collection of phenotypically similar neurodegenerative conditions that mimic many of its core features.
Fogel BL, Clark MC, Geschwind DH.
europepmc +8 more sources
Cerebrospinal fluid biomarker candidates for parkinsonian disorders [PDF]
Frontiers in Neurology, 2013 The parkinsonian disorders are a large group of neurodegenerative diseases including idiopathic Parkinson's disease (PD) and atypical parkinsonian disorders, such as multiple system atrophy, progressive supranuclear palsy, corticobasal degeneration, and ...
Radu eConstantinescu, Stefania eMondello
doaj +6 more sources
Low dose Amantadine and Escitalopram combination in Atypical Parkinsonian disorders- A Retrospective chart review [PDF]
European Psychiatry, 2023 Introduction The response to conventional antiparkinsonian medications is elusive in atypical parkinsonian disorders. Improvement in parkinsonian symptoms in atypical parkinsonian disorders has been reported with anecdotal use of Amantadine. The role of
S. M. Tripathi, P. Chutia
doaj +2 more sources